Cosmo Pharmaceuticals NV
SIX:COPN

Watchlist Manager

Cosmo Pharmaceuticals NV

SIX:COPN

Watchlist

Dividends

Discount Rate

Price: 65 CHF Market Closed

Market Cap: 1B CHF

Have any thoughts about
Cosmo Pharmaceuticals NV?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Estee Lauder Companies Inc NYSE:EL	Consumer products
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Church & Dwight Co Inc NYSE:CHD	Consumer products
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	American Express Co NYSE:AXP	Financial Services
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Target Corp NYSE:TGT	Retail
US	Walt Disney Co NYSE:DIS	Media
US	Mueller Industries Inc NYSE:MLI	Machinery
US	PayPal Holdings Inc NASDAQ:PYPL	Technology

Add Price Alert

Price Target:

Last Price: 65 CHF

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

COPN Alert

Cosmo Pharmaceuticals NV

0 (0%)

52 Week Range	37.8 79.9
Price Target

We'll email you a reminder when the closing price reaches CHF.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Estee Lauder Companies Inc NYSE:EL	US
	Exxon Mobil Corp NYSE:XOM	US
	Church & Dwight Co Inc NYSE:CHD	US
	Pfizer Inc NYSE:PFE	US
	American Express Co NYSE:AXP	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Target Corp NYSE:TGT	US
	Walt Disney Co NYSE:DIS	US
	Mueller Industries Inc NYSE:MLI	US
	PayPal Holdings Inc NASDAQ:PYPL	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Cosmo Pharmaceuticals NV

What unique competitive advantages
does Cosmo Pharmaceuticals NV hold over its rivals?

What risks and challenges
does Cosmo Pharmaceuticals NV face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Cosmo Pharmaceuticals NV.

What unique competitive advantages
does Cosmo Pharmaceuticals NV hold over its rivals?

What risks and challenges
does Cosmo Pharmaceuticals NV face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Cosmo Pharmaceuticals NV.

Provide P/S
for Cosmo Pharmaceuticals NV.

Provide P/E
for Cosmo Pharmaceuticals NV.

Provide P/OCF
for Cosmo Pharmaceuticals NV.

Provide P/FCFE
for Cosmo Pharmaceuticals NV.

Provide P/B
for Cosmo Pharmaceuticals NV.

Provide EV/S
for Cosmo Pharmaceuticals NV.

Provide EV/GP
for Cosmo Pharmaceuticals NV.

Provide EV/EBITDA
for Cosmo Pharmaceuticals NV.

Provide EV/EBIT
for Cosmo Pharmaceuticals NV.

Provide EV/OCF
for Cosmo Pharmaceuticals NV.

Provide EV/FCFF
for Cosmo Pharmaceuticals NV.

Provide EV/IC
for Cosmo Pharmaceuticals NV.

Show me price targets
for Cosmo Pharmaceuticals NV made by professional analysts.

What are the Revenue projections
for Cosmo Pharmaceuticals NV?

How accurate were the past Revenue estimates
for Cosmo Pharmaceuticals NV?

What are the Net Income projections
for Cosmo Pharmaceuticals NV?

How accurate were the past Net Income estimates
for Cosmo Pharmaceuticals NV?

What are the EPS projections
for Cosmo Pharmaceuticals NV?

How accurate were the past EPS estimates
for Cosmo Pharmaceuticals NV?

What are the EBIT projections
for Cosmo Pharmaceuticals NV?

How accurate were the past EBIT estimates
for Cosmo Pharmaceuticals NV?

Compare the revenue forecasts
for Cosmo Pharmaceuticals NV with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Cosmo Pharmaceuticals NV and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Cosmo Pharmaceuticals NV against its competitors.

Analyze the profit margins
(gross, operating, and net) of Cosmo Pharmaceuticals NV compared to its peers.

Compare the P/E ratios
of Cosmo Pharmaceuticals NV against its peers.

Discuss the investment returns and shareholder value creation
comparing Cosmo Pharmaceuticals NV with its peers.

Analyze the financial leverage
of Cosmo Pharmaceuticals NV compared to its main competitors.

Show all profitability ratios
for Cosmo Pharmaceuticals NV.

Provide ROE
for Cosmo Pharmaceuticals NV.

Provide ROA
for Cosmo Pharmaceuticals NV.

Provide ROIC
for Cosmo Pharmaceuticals NV.

Provide ROCE
for Cosmo Pharmaceuticals NV.

Provide Gross Margin
for Cosmo Pharmaceuticals NV.

Provide Operating Margin
for Cosmo Pharmaceuticals NV.

Provide Net Margin
for Cosmo Pharmaceuticals NV.

Provide FCF Margin
for Cosmo Pharmaceuticals NV.

Show all solvency ratios
for Cosmo Pharmaceuticals NV.

Provide D/E Ratio
for Cosmo Pharmaceuticals NV.

Provide D/A Ratio
for Cosmo Pharmaceuticals NV.

Provide Interest Coverage Ratio
for Cosmo Pharmaceuticals NV.

Provide Altman Z-Score Ratio
for Cosmo Pharmaceuticals NV.

Provide Quick Ratio
for Cosmo Pharmaceuticals NV.

Provide Current Ratio
for Cosmo Pharmaceuticals NV.

Provide Cash Ratio
for Cosmo Pharmaceuticals NV.

What is the historical Revenue growth
over the last 5 years for Cosmo Pharmaceuticals NV?

What is the historical Net Income growth
over the last 5 years for Cosmo Pharmaceuticals NV?

What is the current Free Cash Flow
of Cosmo Pharmaceuticals NV?

Discuss the annual earnings per share (EPS)
trend over the past five years for Cosmo Pharmaceuticals NV.

COPN

Income Statement

Interest Income Expense

Cosmo Pharmaceuticals NV
Interest Income Expense

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

Adjust for Inflation

Cosmo Pharmaceuticals NV
Interest Income Expense Peer Comparison

Comparables:

PRGO

JAZZ

AVDL

GHRS

OVB

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company		Interest Income Expense	CAGR 3Y	CAGR 5Y	CAGR 10Y
	Cosmo Pharmaceuticals NV SIX:COPN	Interest Income Expense €703k	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years -37%
	Perrigo Company PLC NYSE:PRGO	Interest Income Expense -$189.4m	CAGR 3-Years -13%	CAGR 5-Years -5%	CAGR 10-Years -6%
	Jazz Pharmaceuticals PLC NASDAQ:JAZZ	Interest Income Expense -$249.7m	CAGR 3-Years -5%	CAGR 5-Years -26%	CAGR 10-Years -21%
	Avadel Pharmaceuticals PLC NASDAQ:AVDL	Interest Income Expense -$9.6m	CAGR 3-Years 3%	CAGR 5-Years 5%	CAGR 10-Years -4%
G	GH Research PLC NASDAQ:GHRS	Interest Income Expense $2.7m	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A
	Ovoca Bio PLC LSE:OVB	Interest Income Expense €9k	CAGR 3-Years -53%	CAGR 5-Years -54%	CAGR 10-Years -35%

What is Cosmo Pharmaceuticals NV's Interest Income Expense?

Interest Income Expense
703k EUR

Based on the financial report for Jun 30, 2024, Cosmo Pharmaceuticals NV's Interest Income Expense amounts to 703k EUR.

Cosmo Pharmaceuticals NV
SIX:COPN

Cosmo Pharmaceuticals NV
Interest Income Expense

Cosmo Pharmaceuticals NV
Interest Income Expense Peer Comparison

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

See Also

What is Cosmo Pharmaceuticals NV's Interest Income Expense?

Interest Income Expense
703k EUR

What is Cosmo Pharmaceuticals NV's Interest Income Expense growth rate?

Interest Income Expense CAGR 10Y
-37%

Company

Help

Tools

Stocks

Cosmo Pharmaceuticals NV SIX:COPN

Cosmo Pharmaceuticals NV Interest Income Expense

Cosmo Pharmaceuticals NV Interest Income Expense Peer Comparison

Competitive Interest Income Expense Analysis Latest Figures & CAGR of Competitors

See Also

What is Cosmo Pharmaceuticals NV's Interest Income Expense? Interest Income Expense 703k EUR

What is Cosmo Pharmaceuticals NV's Interest Income Expense growth rate? Interest Income Expense CAGR 10Y -37%

Company

Help

Tools

Stocks

Cosmo Pharmaceuticals NV
SIX:COPN

Cosmo Pharmaceuticals NV
Interest Income Expense

Cosmo Pharmaceuticals NV
Interest Income Expense Peer Comparison

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

What is Cosmo Pharmaceuticals NV's Interest Income Expense?

Interest Income Expense
703k EUR

What is Cosmo Pharmaceuticals NV's Interest Income Expense growth rate?

Interest Income Expense CAGR 10Y
-37%